The Association of the Immune Response Genes to Human Papillomavirus-Related Cervical Disease in a Brazilian Population

Table 6

HLA haplotype frequencies with significant differences between HPV patients and controls.

Haplotypes	Patients 𝑛 (hf)	Controls 𝑛 (hf)	𝑃	OR	CI
HLA-A*02–HLA-B*51	1 (0.006)	16 (0.052)	0.006	0.1186	0.015–0.8717
HLA-A*03–HLA-DRB1*11	7 (0.043)	1 (0.003)	0.002	150.828	1.712–115.230
HLA-B*14–HLA-DRB1*13	5 (0.032)	1 (0.003)	0.017	108.906	1.146–85.504
HLA-B*15–HLA-DRB1*07	5 (0.029)	1 (0.003)	0.017	108.906	1.146–85.505
HLA-B*15–HLA-DRB1*11	7 (0.048)	1 (0.003)	0.002	150.828	1.712–115.230
HLA-B*44–HLA-DRB1*01	6 (0.036)	2 (0.005)	0.018	49.028	1.188–29.885
HLA-B*44–HLA-DRB1*11	7 (0.048)	1 (0.003)	0.002	150.828	1.712–115.230

𝑛: haplotype numbers; hf: haplotype frequencies (%); 𝑃: 𝑃 value; OR: odds ratio; CI (95%): 95% confidence interval.